Endotoxin testing: the future of recombinant methods

Panel Discussion

Information

With an ever-increasing focus on sustainability across the pharmaceutical industry, many companies are looking to recombinant methods for bacterial endotoxin testing. During this vendor-led panel discussion, experts will discuss the latest guidelines and regional variations on recombinant Factor C (rFC) and recombinant Cascade Reagents (rCR). Make sure you join to:

Stay up to date with landscape surrounding the use of rFC and rCR
Learn about different approaches and strategies for method validation
Evaluate different technologies that can support your BET needs.

LonzaLonza is one of the world’s largest healthcare manufacturing organizations, helping pharmaceutical, biotech and nutrition companies to bring their treatments to market. United by our vision to bring any therapy to life, we support our customers with a combination of technological insight, world-class manufacturing, scientific expertise, process excellence and innovation. Our work enables our customers to develop and commercialize their therapeutic discoveries, allowing their patients to benefit from life-saving and life-enhancing treatments.

Endotoxin testing: the future of recombinant methods

Information

Log in